+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cancer Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Cancer Type, Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977964
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cancer Stem Cells Market grew from USD 4.72 billion in 2023 to USD 5.21 billion in 2024. It is expected to continue growing at a CAGR of 10.55%, reaching USD 9.54 billion by 2030.

Like stem cells that help regenerate tissues and organs by dividing and differentiating into various cell types, cancer stem cells contribute to the formation and perpetuation of tumors. They are particularly significant because they are thought to be responsible for cancer recurrence and resistance to conventional cancer therapies. Understanding cancer stem cells is crucial for developing more effective cancer treatments. The global increase in cancer cases continues to drive demand for innovative treatments. Cancer stem cells (CSCs) are crucial in cancer initiation and recurrence, making products targeting these cells essential. The growing understanding of their role in cancer progression has increased the demand for therapies and diagnostics focusing on cancer stem cells. However, strict regulations associated with the approvals and lack of standardization protocols are significant challenges the companies face. Moreover, innovations in stem cell research, genomics, and biotechnology have propelled forward the methods available for studying CSCs. Integrating gene therapy techniques with CSC research offers promising avenues for eradicating CSCs at the genetic level.

Regional Insights

In the Americas, particularly the United States and Canada, there is a high prevalence of cancer, which has supported a strong infrastructure for cancer research, including studies on cancer stem cells. Both countries exhibit advanced healthcare systems and significant investments in biotechnology research. The United States leads in global cancer stem cell research due to substantial government and private funding. Numerous patents have been filed in the United States concerning cancer stem cell therapies and diagnostics innovations. European Union countries maintain a robust framework for cancer research facilitated by support from various EU policies and funding mechanisms, such as Horizon Europe. The EU's interest in personalized medicine has led to increased attention on cancer stem cells, considering their role in the efficacy of individualized treatment plans. There are ongoing investments in exploring novel therapies that target these cells. Moreover, the Asia Pacific region represents a dynamic area for cancer stem cell research, showcasing significant activity in terms of patents, particularly in China and Japan. Both countries have strong national policies supporting biotechnology and medical research, with substantial government funding. Japan, known for its rapid technology adoption, shows a considerable consumer willingness to invest in advanced medical treatments. China has seen a surge in research activities and market opportunities for cancer stem cell therapies. India is also making strides, with increased investment in healthcare and cancer research, though it still faces challenges related to infrastructure and public health priorities.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Cancer Stem Cells Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Growing awareness of cancer worldwide and the need for effective therapeutic options
  • Supportive government policies and incentives for stem cell research

Market Restraints

  • Stringent regulatory frameworks for stem cell research

Market Opportunities

  • Innovations in genomics sequencing and biotechnology for cancer research
  • Increased collaboration between academic institutions and biopharmaceutical companies for stem cell research

Market Challenges

  • Complexities associated with the heterogeneity and plasticity of cancer stem cells

Market Segmentation Analysis

  • Type: Utilization of hESCs in cancer biology to understand cancer mechanisms and support the development of targeted cancer therapies
  • Cancer Type: Increasing usage of cancer stem cells in varied cancer diagnoses to necessitates effective treatments and therapies

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cancer Stem Cells Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cancer Stem Cells Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

StemCell Technologies Enhances Portfolio with Propagenix Acquisition to Advance Cancer Stem Cell Research

StemCell Technologies, a player in the biotechnology sector, has strategically acquired Propagenix, a company well-regarded for its innovative cell propagation technologies. This acquisition is set to significantly bolster StemCell Technologies' capabilities in cancer stem cell research. Propagenix has developed a unique technology that simplifies and enhances the growth of primary human epithelial cells, which are crucial for cancer research. By integrating these advanced methods, StemCell Technologies aims to accelerate the development of more effective cancer treatments.

AstraZeneca Enhances Cell Therapy Capabilities with Gracell Biotechnologies Acquisition

AstraZeneca announced the acquisition of Gracell Biotechnologies, marking a significant expansion in its oncology and autoimmune disease treatment sectors. This strategic move aims to harness Gracell's innovative cell therapy technologies, which include efficient, cost-effective methods of producing genetically modified cell therapies. Such therapies are crucial for treating various cancer types and autoimmune disorders effectively. AstraZeneca's acquisition is poised to boost its research capabilities while potentially accelerating the delivery of new, transformative treatment options to patients worldwide. This partnership underscores AstraZeneca's commitment to advancing healthcare through cutting-edge biotechnological innovations.

Max Healthcare Initiates Advanced CAR-T Cell Therapy in Partnership with ImmunoACT

Max Healthcare introduced Chimeric Antigen Receptor T-cell (CAR-T) therapy for patients. This innovative cancer treatment is a result of their collaboration with ImmunoACT, demonstrating a significant leap in cancer care technology in the region. CAR-T therapy, a form of immunotherapy, utilizes genetically modified T-cells from the patient's immune system to effectively target and eliminate cancer cells. This treatment has primarily been utilized for blood cancers, such as lymphoma and leukemia, and its introduction in India marks a pivotal advancement, providing new hope for patients and potentially heralding a new era in the treatment of resistant and relapsed cases of cancer.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cancer Stem Cells Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cancer Stem Cells Market, highlighting leading vendors and their innovative profiles. These include AcceGen, Becton, Dickinson and Company, Bio-Techne Corporation, Biorestorative Therapies Inc., BrainStorm Cell Limited, Gamida Cell Ltd., GenScript Biotech Corporation, JCR Pharmaceuticals Co., Ltd., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Novartis AG, Qiagen N.V, Sartorius AG, STEMCELL Technologies Canada Inc., Takara Bio Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cancer Stem Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

  • Adult Stem Cell
  • Human Embryonic Stem Cell
  • Induced Pluripotent Stem Cell

Source

  • Allogenic
  • Autologous

Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer

Application

  • Clinical Research
  • Drug Development
  • Targeted Therapy

End-User

  • Academic & Research Institutes
  • Hospitals & Cell Banks
  • Pharmaceutical & Biotechnology Companies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing awareness of cancer worldwide and the need for effective therapeutic options
5.1.1.2. Supportive government policies and incentives for stem cell research
5.1.2. Restraints
5.1.2.1. Stringent regulatory frameworks for stem cell research
5.1.3. Opportunities
5.1.3.1. Innovations in genomics sequencing and biotechnology for cancer research
5.1.3.2. Increased collaboration between academic institutions and biopharmaceutical companies for stem cell research
5.1.4. Challenges
5.1.4.1. Complexities associated with the heterogeneity and plasticity of cancer stem cells
5.2. Market Segmentation Analysis
5.2.1. Type: Utilization of hESCs in cancer biology to understand cancer mechanisms and support the development of targeted cancer therapies
5.2.2. Cancer Type: Increasing usage of cancer stem cells in varied cancer diagnoses to necessitates effective treatments and therapies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cancer Stem Cells Market, by Type
6.1. Introduction
6.2. Adult Stem Cell
6.3. Human Embryonic Stem Cell
6.4. Induced Pluripotent Stem Cell
7. Cancer Stem Cells Market, by Source
7.1. Introduction
7.2. Allogenic
7.3. Autologous
8. Cancer Stem Cells Market, by Cancer Type
8.1. Introduction
8.2. Breast Cancer
8.3. Lung Cancer
8.4. Prostate Cancer
9. Cancer Stem Cells Market, by Application
9.1. Introduction
9.2. Clinical Research
9.3. Drug Development
9.4. Targeted Therapy
10. Cancer Stem Cells Market, by End-User
10.1. Introduction
10.2. Academic & Research Institutes
10.3. Hospitals & Cell Banks
10.4. Pharmaceutical & Biotechnology Companies
11. Americas Cancer Stem Cells Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Cancer Stem Cells Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Cancer Stem Cells Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.3.1. StemCell Technologies Enhances Portfolio with Propagenix Acquisition to Advance Cancer Stem Cell Research
14.3.2. AstraZeneca Enhances Cell Therapy Capabilities with Gracell Biotechnologies Acquisition
14.3.3. Max Healthcare Initiates Advanced CAR-T Cell Therapy in Partnership with ImmunoACT
14.4. Strategy Analysis & Recommendation
15. Competitive Portfolio
15.1. Key Company Profiles
15.2. Key Product Portfolio
List of Figures
FIGURE 1. CANCER STEM CELLS MARKET RESEARCH PROCESS
FIGURE 2. CANCER STEM CELLS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CANCER STEM CELLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CANCER STEM CELLS MARKET DYNAMICS
FIGURE 7. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. CANCER STEM CELLS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 26. CANCER STEM CELLS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CANCER STEM CELLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CANCER STEM CELLS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CANCER STEM CELLS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CANCER STEM CELLS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ADULT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HUMAN EMBRYONIC STEM CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CANCER STEM CELLS MARKET SIZE, BY INDUCED PLURIPOTENT STEM CELL, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ALLOGENIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CANCER STEM CELLS MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER STEM CELLS MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CANCER STEM CELLS MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER STEM CELLS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CANCER STEM CELLS MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CANCER STEM CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CANCER STEM CELLS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CANCER STEM CELLS MARKET SIZE, BY TARGETED THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CANCER STEM CELLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CANCER STEM CELLS MARKET SIZE, BY HOSPITALS & CELL BANKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CANCER STEM CELLS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 75. BRAZIL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 76. BRAZIL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 77. CANADA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 78. CANADA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 79. CANADA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 80. CANADA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 81. CANADA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 82. CANADA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 83. CANADA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. CANADA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. CANADA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. CANADA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. MEXICO CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. MEXICO CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. MEXICO CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 90. MEXICO CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 91. MEXICO CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 92. MEXICO CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 93. MEXICO CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 94. MEXICO CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 95. MEXICO CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 96. MEXICO CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 101. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 102. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 103. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 104. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 105. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 108. UNITED STATES CANCER STEM CELLS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 111. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 112. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 113. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 114. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 115. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 116. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 117. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 120. ASIA-PACIFIC CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 121. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 122. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 123. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 124. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 125. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 126. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 127. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. AUSTRALIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. CHINA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. CHINA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. CHINA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 134. CHINA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 135. CHINA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 136. CHINA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 137. CHINA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. CHINA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. CHINA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 140. CHINA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 141. INDIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. INDIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. INDIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 144. INDIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 145. INDIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 146. INDIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 147. INDIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 148. INDIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 149. INDIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. INDIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. INDONESIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 152. INDONESIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 153. INDONESIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 154. INDONESIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 155. INDONESIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 156. INDONESIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 157. INDONESIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 158. INDONESIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 159. INDONESIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. INDONESIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. JAPAN CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. JAPAN CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. JAPAN CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 164. JAPAN CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 165. JAPAN CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 166. JAPAN CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 167. JAPAN CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 168. JAPAN CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 169. JAPAN CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 170. JAPAN CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 171. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 172. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 173. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 174. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 175. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 176. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 177. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 178. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 179. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. MALAYSIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 184. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 185. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 186. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 187. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. PHILIPPINES CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 194. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 195. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 196. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 197. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 198. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 199. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 200. SINGAPORE CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 201. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 204. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 205. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 206. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 207. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 208. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 209. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. SOUTH KOREA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. TAIWAN CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. TAIWAN CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. TAIWAN CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 214. TAIWAN CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 215. TAIWAN CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 216. TAIWAN CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 217. TAIWAN CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. TAIWAN CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. TAIWAN CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 220. TAIWAN CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 221. THAILAND CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. THAILAND CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. THAILAND CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 224. THAILAND CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 225. THAILAND CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 226. THAILAND CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 227. THAILAND CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. THAILAND CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. THAILAND CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 230. THAILAND CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 231. VIETNAM CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 232. VIETNAM CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 233. VIETNAM CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 234. VIETNAM CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 235. VIETNAM CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 236. VIETNAM CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 237. VIETNAM CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 238. VIETNAM CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 239. VIETNAM CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. VIETNAM CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA CANCER STEM CELLS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 253. DENMARK CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. DENMARK CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. DENMARK CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 256. DENMARK CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 257. DENMARK CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 258. DENMARK CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 259. DENMARK CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. DENMARK CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. DENMARK CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 262. DENMARK CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 263. EGYPT CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. EGYPT CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. EGYPT CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 266. EGYPT CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 267. EGYPT CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 268. EGYPT CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 269. EGYPT CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. EGYPT CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. EGYPT CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. EGYPT CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. FINLAND CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 274. FINLAND CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 275. FINLAND CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 276. FINLAND CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 277. FINLAND CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 278. FINLAND CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 279. FINLAND CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 280. FINLAND CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 281. FINLAND CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. FINLAND CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. FRANCE CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. FRANCE CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. FRANCE CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 286. FRANCE CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 287. FRANCE CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 288. FRANCE CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 289. FRANCE CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 290. FRANCE CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 291. FRANCE CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 292. FRANCE CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 293. GERMANY CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 294. GERMANY CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 295. GERMANY CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 296. GERMANY CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 297. GERMANY CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 298. GERMANY CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 299. GERMANY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 300. GERMANY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 301. GERMANY CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 302. GERMANY CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 303. ISRAEL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 304. ISRAEL CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 305. ISRAEL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 306. ISRAEL CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 307. ISRAEL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 308. ISRAEL CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 309. ISRAEL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. ISRAEL CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. ISRAEL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. ISRAEL CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 313. ITALY CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 314. ITALY CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 315. ITALY CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 316. ITALY CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 317. ITALY CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 318. ITALY CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 319. ITALY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 320. ITALY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 321. ITALY CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 322. ITALY CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 323. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 324. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 325. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 326. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 327. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 328. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 329. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 330. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 331. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 332. NETHERLANDS CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 333. NIGERIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 334. NIGERIA CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 335. NIGERIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 336. NIGERIA CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 337. NIGERIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 338. NIGERIA CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 339. NIGERIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. NIGERIA CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. NIGERIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 342. NIGERIA CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 343. NORWAY CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 344. NORWAY CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 345. NORWAY CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 346. NORWAY CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 347. NORWAY CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 348. NORWAY CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 349. NORWAY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 350. NORWAY CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 351. NORWAY CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 352. NORWAY CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 353. POLAND CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 354. POLAND CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 355. POLAND CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 356. POLAND CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 357. POLAND CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 358. POLAND CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2024-2030 (USD MILLION)
TABLE 359. POLAND CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 360. POLAND CANCER STEM CELLS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 361. POLAND CANCER STEM CELLS MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 362. POLAND CANCER STEM CELLS MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 363. QATAR CANCER STEM CELLS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 364. QATAR CANCER STEM CELLS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 365. QATAR CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 366. QATAR CANCER STEM CELLS MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 367. QATAR CANCER STEM CELLS MARKET SIZE, BY CANCER TYPE, 2018-2023 (USD MILLION)
TABLE 368. QATAR CANCER STEM CELLS MARKET SIZE,

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AcceGen
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • Biorestorative Therapies Inc.
  • BrainStorm Cell Limited
  • Gamida Cell Ltd.
  • GenScript Biotech Corporation
  • JCR Pharmaceuticals Co., Ltd.
  • Lonza Group Ltd.
  • Merck KGaA
  • Miltenyi Biotec B.V. & Co. KG
  • Novartis AG
  • Qiagen N.V
  • Sartorius AG
  • STEMCELL Technologies Canada Inc.
  • Takara Bio Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.21 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.54 Billion
Compound Annual Growth Rate10.5%
Regions CoveredGlobal

Related Topics

Related Reports

Cancer Stem Cells Market Share, Size & Trends Analysis Report By Mode Of Action (Stem Cell based Cancer Therapy, Targeted CSCs), By Cancer Forms (Breast Cancer, Bladder Cancer), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Cancer Stem Cells Market Share, Size & Trends Analysis Report By Mode Of Action (Stem Cell based Cancer Therapy, Targeted CSCs), By Cancer Forms (Breast Cancer, Bladder Cancer), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 200 Pages
  • Global
From
Adult Stem Cells Market Size, Share & Trend Analysis Report By Type (Autologous Adult Stem Cells, Allogeneic Adult Stem Cells), By Product & Services (Product, Services), By Indication, By Application, By End Use, And Segment Forecasts, 2024 - 2030 - Product Image

Adult Stem Cells Market Size, Share & Trend Analysis Report By Type (Autologous Adult Stem Cells, Allogeneic Adult Stem Cells), By Product & Services (Product, Services), By Indication, By Application, By End Use, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Cancer Stem Cells - Global Strategic Business Report - Product Image

Cancer Stem Cells - Global Strategic Business Report

  • Report
  • 89 Pages
  • Global
From
Global Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Forecast 2024-2030 - Product Image

Global Stem Cells Market by Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell), Source (Allogenic, Autologous), Application, End-user - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Circulating Tumor Cells and Cancer Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Circulating Tumor Cells and Cancer Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 200 Pages
  • Global

About the Market

The Cancer Stem Cell (CSC) market is a subset of the larger stem cell market. CSCs are a type of stem cell that can cause cancer when they divide and grow uncontrollably. CSCs are believed to be responsible for the recurrence of cancer after treatment, and are the focus of much research into new treatments. CSCs are also being studied for their potential to be used in regenerative medicine. CSCs are being studied for their potential to be used in personalized medicine, where treatments are tailored to the individual patient. CSCs are also being studied for their potential to be used in drug discovery and development, as they can be used to test the effectiveness of new drugs. The CSC market is a rapidly growing field, with many companies investing in research and development. Companies such as Celgene, Novartis, and AstraZeneca are investing in CSC research, while companies such as Thermo Fisher Scientific and Bio-Rad are providing tools and services to support CSC research. Other companies such as StemCell Technologies and STEMCELL Technologies are providing products and services to support CSC research. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.